









Markets
/
Stocks
/
nasdaq-cvs
/

CVS Health Corp

CVS

72.673USD

-2.307-3.08%

Market hours （ET）Quotes delayed by 15 min

92.08BMarket Cap

20.32P/E TTM



CVS Health Corp

72.673

-2.307-3.08%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-12

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

17 / 72

Overall Ranking

133 / 4724

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 29 analysts

Buy

Current Rating

80.635

Target Price

+7.54%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

CVS Health Corporation is a health solutions company. The Company operates in four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Its Health Care Benefits segment offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services segment provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services, including pharmacy patient care programs, diagnostic testing and vaccination administration.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 372.81B.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 15.61% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 73.28%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 73.28%.

Fairly Valued

The company’s latest PE is 20.90, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 1.12B shares, increasing 1.03% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 119.78M shares of this stock.

Financial Health

Currency: USD Updated：2025-09-12

The company's current financial score is 5.42, which is lower than the Healthcare Providers & Services industry's average of 7.15. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 94.59B, representing a year-over-year increase of 6.96%, while its net profit experienced a year-over-year increase of 59.84%.

Score

Industry at a Glance

Previous score

5.42

Change



Financials

4.86

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.86

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

4.87

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

4.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

6.51

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-12

The company’s current valuation score is 4.80, which is higher than the Healthcare Providers & Services industry's average of 2.15. Its current P/E ratio is 20.05, which is 10.76% below the recent high of 22.20 and 40.81% above the recent low of 11.86.

Score

Industry at a Glance

Previous score

4.94

Change

-0.02

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 17/72

No Data

Earnings Forecast

Currency: USD Updated：2025-09-12

The company’s current earnings forecast score is 7.72, which is higher than the Healthcare Providers & Services industry's average of 7.66. The average price target for CVS Health Corp is 80.00, with a high of 99.00 and a low of 70.00.

Score

Industry at a Glance

Previous score

7.93

Change

Support & Resistance

No Data

Analyst Rating

Based on 29 analysts

Buy

Current Rating

80.635

Target Price

+7.54%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

Natera Inc

NTRA

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-12

The company’s current price momentum score is 9.52, which is higher than the Healthcare Providers & Services industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 75.76 and the support level at 64.65, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.41

Change

-0.07

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

-0.019

Neutral

RSI(14)

67.552

Neutral

STOCH(KDJ)(9,3,3)

85.444

Buy

ATR(14)

1.624

High Vlolatility

CCI(14)

133.682

Buy

Williams %R

9.580

Overbought

TRIX(12,20)

0.491

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

73.126

Sell

MA10

73.366

Sell

MA20

72.189

Buy

MA50

67.006

Buy

MA100

66.056

Buy

MA200

62.403

Buy

Institutional Confidence

Currency: USD Updated：2025-09-12

The company’s current institutional recognition score is 7.00, which is lower than the Healthcare Providers & Services industry's average of 7.19. The latest institutional shareholding proportion is 88.15%, representing a quarter-over-quarter decrease of 0.74%. The largest institutional shareholder is The Vanguard, holding a total of 119.78M shares, representing 9.44% of shares outstanding, with 1.78% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

117.73M

+0.83%

Dodge & Cox

Star Investors

73.46M

+4.78%

Capital World Investors

68.40M

+12.06%

BlackRock Institutional Trust Company, N.A.

64.96M

+8.11%

State Street Global Advisors (US)

57.99M

+1.82%

Fidelity Management & Research Company LLC

24.22M

+14.57%

Geode Capital Management, L.L.C.

27.96M

+3.36%

Capital International Investors

26.19M

-1.80%

Norges Bank Investment Management (NBIM)

18.70M

+25.51%

Pzena Investment Management, LLC

Star Investors

17.68M

-9.83%

Risk Assessment

Currency: USD Updated：2025-09-12

The company's beta value is 0.62. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.